Starting tomorrow you'll be able to buy a powerful over-the-counter weight loss pill called Alli. It's only half the strength of its prescription counterpart, but much cheaper. Jaime Bedrin reports.
Sales of Alli are projected to be as high as $3 billion a year, but angry critics say once it's available over-the-counter there's nothing to stop it from becoming a dangerous drug for teens and people with eating disorders. Helen Palmer reports.
Britain's largest defense contractor managed to escape U.K. inquiries into secret payments made in a massive arms deal, but now that those payments have been traced to a U.S. bank account, the DOJ will likely launch its own investigation. Stephen Beard reports.
Southwest carries more passengers than any other U.S. airline, but profits are sagging and there are seats to fill so it's finally going to sell tickets through the same booking engine other airlines use. But you're still not getting an assigned seat, Jill Barshay reports.
About a quarter of Americans currently infected with HIV don't know they're living with the virus, but the public health community is divided over the best way to find and treat that population. Janet Babin explains.
Chris Farrell says the inflation fears gripping the economic community are being addressed to such a degree that inflation is likely to just disappear. And they might actually be creating a buying opportunity for bonds.
The sub-prime loan market collapse is tearing apart neighborhoods. But hedge fund managers are worried their insurance policies won't pay out if the federal government intervenes. Steve Henn reports.